Posts Tagged ‘MELA’

Hot NASDAQ Performing Pharma Stocks: (MELA, CYTX, ACOR, SVNT, MRNA)

Posted on March 3rd, 2011 by rehan1505  |  No Comments »

MELA Sciences, Inc. (NASDAQ:MELA) is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (in the doctor’s office) instrument to assist in the early diagnosis of melanoma. It reported the gain of 20.39% and closed at $3.07 whereas overall traded volume stood at 3.90 million shares for the day. [...]

NASDAQ Performing Pharma Stocks: (MELA, CYTX, ACOR, SVNT, MRNA)

Posted on March 3rd, 2011 by rehan1505  |  No Comments »

MELA Sciences, Inc. (NASDAQ:MELA) reported the gain of 20.39% and closed at $3.07 whereas overall traded volume stood at 3.90 million shares for the day. The current market price is 3.37% more than its last 50 days simple moving average. The share price is likely to move by 0.82 times against 1 point in market [...]

Performing Pharma Stocks at NASDAQ: (ARNA, WCRX, AVNR, SNSS, MELA)

Posted on January 2nd, 2011 by rehan1505  |  No Comments »

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs).It gained by 0.58% and closed at $1.72 whereas overall traded volume stood at 3.41 million shares for the day. The current market price is 11.31% more than its last 50 days simple [...]

High momentum movements at NASDSAQ healthcare sector: (MELA, AEZS, ASTM, CBRX, ADLS)

Posted on December 6th, 2010 by rehan1505  |  No Comments »

MELA Sciences, Inc. (NASDAQ: MELA) is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (in the doctor’s office) instrument to assist in the early diagnosis of melanoma. It went up by 4.62% to close at $3.40 whereas overall traded volume stood at 1.53 million shares for the day. [...]

NASDAQ healthcare sector major corrections: (MELA, ASTM, STEM, AEZS, DVAX)

Posted on November 24th, 2010 by rehan1505  |  No Comments »

MELA Sciences, Inc. (NASDAQ: MELA) dropped by 8.90% and closed at $3.99 whereas overall traded volume stood at 4.17 million shares for the day. The value of 38.80 times depicts shows that the relative strength index is in oversold level. The beta value is likely to move by 0.86 times against 1 point change in [...]

NASDAQ healthcare sector top bulls: (CYTR, ARNA, APRI, FONR, MELA)

Posted on November 21st, 2010 by rehan1505  |  No Comments »

CytRx Corporation (NASDAQ: CYTR) surged by 8.16% to close at $1.06 with overall traded volume of 1.47 million shares in the last trading day. The value of 71.99 times depicts shows that the relative strength index is in highly overbought level. The share price is likely to move by 1.53 times against 1 point change [...]

NASDAQ healthcare sector top bulls: (HTWR, MELA, HGSI, APRI, EXEL)

Posted on November 16th, 2010 by rehan1505  |  No Comments »

HeartWare International Inc (NASDAQ: HTWR) surged by 19.26% and closed at $86.18 with overall traded volume of 1.27 million shares in the last trading day. The value of 81.76 times depicts shows that the relative strength index is in highly overbought level. Its total market capitalization stood at 1.20 billion. MELA Sciences, Inc. (NASDAQ: MELA) [...]

Top losing pharmaceutical stocks at NASDAQ: (MITI, HGSI, OXGN, EXEL, MELA)

Posted on November 15th, 2010 by rehan1505  |  No Comments »

Micromet Inc. (NASDAQ: MITI) reported the fall of 6.43% to close at $6.55 whereas overall traded volume stood at 1.18 million shares for the day. The share price is at its oversold level with relative strength index of 36.49 times till its last trading session. The share price is likely to move by 1.44 times [...]